New York, New York, September 17, 2026
DarioHealth Corp. has announced a new contract with one of New Jersey’s largest health plans, representing approximately 1.5 million covered lives, expanding access to the company’s AI-powered digital healthcare platform. The agreement was secured through DarioHealth’s strategic channel partnership with Amwell and is expected to launch and begin generating revenue in the first quarter of 2027. The contract expands DarioHealth’s reach across large health plan populations and provides an opportunity to deliver its cardiometabolic care solutions to self-funded employer groups through the health plan’s administrative services only structure. The agreement also represents the third large state health plan contract DarioHealth has secured through Amwell during the past 12 months, following agreements involving health plans in Arizona and Florida.
DarioHealth Expands AI-Powered Cardiometabolic Care
The new agreement will give eligible populations access to DarioHealth’s cardiometabolic solutions, which are designed to support the management of chronic conditions through digital engagement, personalized interventions and provider-backed care. The company’s integrated platform addresses conditions and health needs including diabetes, hypertension and weight management, while also supporting musculoskeletal and behavioral health programs. DarioHealth combines connected devices, healthcare data, personalized member engagement and artificial intelligence to provide individualized support for people managing chronic conditions. The New Jersey health plan operates as an administrative services only (ASO) health plan, creating an avenue for DarioHealth to reach self-funded employer groups through the payer relationship. Rather than relying exclusively on direct sales to individual employers, Dario’s channel strategy allows healthcare technology services to be distributed through established health plan and healthcare technology partners. According to the company, the latest agreement demonstrates the potential scale of this distribution model by providing access to approximately 1.5 million covered lives through a single contract.
Amwell Partnership Extends Dario’s Market Reach
The contract further strengthens DarioHealth’s relationship with Amwell, which serves as an important channel partner for the company’s healthcare technology platform. Dario said the New Jersey agreement follows previously secured contracts with major health insurers in Arizona and Florida, making it the third large state health plan signed through the Amwell channel during the past year. The company views these agreements as a way to expand access to large payer populations while reducing dependence on a traditional direct-sales approach. DarioHealth’s platform has evolved beyond digital self-management tools to include provider-backed clinical care, allowing healthcare organizations and employers to combine technology-enabled engagement with professional healthcare services. This integrated model is intended to support members across multiple chronic conditions rather than requiring separate solutions for individual diseases. The company has also incorporated its DarioIQ artificial intelligence capabilities, which are designed to personalize engagement by analyzing biometric, clinical and behavioral information.
Advertisement
Platform Uses AI and Longitudinal Healthcare Data
DarioHealth reports that its AI platform is powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade. The company says these data are used to help personalize interventions by analyzing individual biometric, clinical and behavioral information. The platform combines connected health devices, AI-driven insights, personalized engagement and provider-backed care within a broader chronic-care management system. The upcoming New Jersey program is expected to begin generating revenue in Q1 2027, although the timing remains a forward-looking expectation from the company. The agreement represents an expansion of DarioHealth’s commercial footprint in digital chronic-care management and illustrates the growing role of AI-powered healthcare technology in employer and health-plan populations.
For cGxP.wire readers, the announcement highlights the intersection of digital health, artificial intelligence, chronic disease management and healthcare payer partnerships. As DarioHealth continues expanding through channel partners, the New Jersey contract provides a significant new deployment opportunity for its cardiometabolic platform and provider-backed care model.
Source: DarioHealth press release
